Healio

VIDEO: Treatment outlook ‘rapidly changing’ in primary sclerosing cholangitis

Please provide your email address to receive an email when new articles are posted on . “Traditionally, we haven’t paid a lot of attention to symptoms in PSC, except when patients have acute ...
Medscape

Pruritus Exhausts Patients With Primary Sclerosing Cholangitis

Clinically diagnosed pruritus significantly affected fatigue and antidepressant use in adults with primary sclerosing cholangitis (PSC), based on data from nearly 5000 patients presented at The Liver ...
Medscape

Drug Slows Progression of Primary Sclerosing Cholangitis

AMSTERDAM — Norucholic acid (NCA), an investigational therapy, demonstrated significant superiority over placebo in halting disease progression in patients with primary sclerosing cholangitis (PSC), ...
Business Wire

Volixibat Granted Breakthrough Therapy Designation for Cholestatic Pruritus in Primary Biliary Cholangitis

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to ...

New monoclonal antibody could be a game-changer in treating rare liver disease by reducing inflammation and fibrosis, says new study

PSC occurs in 1 out of 10,000 people, who are mostly male adults between 30 and 60 years old, and it commonly develops in patients with inflammatory bowel disease who have ulcerative colitis. The lack ...